Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
    Published on 2023-04-28
    2 years ago
  • Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow
    Published on 2023-04-28
    2 years ago
  • The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
    Published on 2023-04-25
    2 years ago
  • AI-based analysis of social media language predicts addiction treatment dropout at 90 days
    Published on 2023-04-24
    2 years ago
  • Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial
    Published on 2023-04-19
    2 years ago
  • Transdiagnostic evaluation of epigenetic age acceleration and burden of psychiatric disorders
    Published on 2023-04-17
    2 years ago
  • LPA1 receptors in the lateral habenula regulate negative affective states associated with alcohol withdrawal
    Published on 2023-04-14
    2 years ago
« Previous 1 … 82 83 84 85 86 … 143 Next »
Journal of Psychopharmacology
  • The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling
    Published on 2020-10-24
    5 years ago
  • Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment
    Published on 2020-10-21
    5 years ago
  • Histamine H3 receptor gene variants associated with drug abuse in patients with cocaine use disorder
    Published on 2020-10-16
    5 years ago
  • Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking
    Published on 2020-10-16
    5 years ago
  • The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence
    Published on 2020-10-11
    5 years ago
  • Paternal exposure to morphine during adolescence potentiates morphine withdrawal in male offspring: Involvement of the lateral paragigantocellularis nucleus
    Published on 2020-10-09
    5 years ago
  • Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention
    Published on 2020-10-09
    5 years ago
« Previous 1 … 82 83 84 85 86 … 123 Next »
European Neuropsychopharmacology
  • Tiagabine induced modulation of oscillatory connectivity and activity match PET-derived, canonical GABA-A receptor distributions
    Published on 2021-05-04
    4 years ago
  • Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats
    Published on 2021-05-03
    4 years ago
  • Exploring the relation between BOLD fMRI and cognitive performance using a computer-based quantitative systems pharmacology model: Applications to the COMTVAL158MET genotype and ketamine
    Published on 2021-05-02
    4 years ago
  • Refining biomarker evaluation in ASD
    Published on 2021-04-30
    4 years ago
  • CBD is not converted to THC in rats: A framework interpretation and discussion
    Published on 2021-04-28
    4 years ago
  • Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys
    Published on 2021-04-26
    4 years ago
  • Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
    Published on 2021-04-26
    4 years ago
« Previous 1 … 82 83 84 85 86 … 144 Next »

   Pharma Pub